The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
9986712 |
33 |
A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.![EBI](/images/logo_chembl.png) |
Institute of Mutagenesis and Differentiation |
22483585 |
28 |
Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists.![EBI](/images/logo_chembl.png) |
Gedeon Richter |
18061443 |
34 |
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.![EBI](/images/logo_chembl.png) |
Merck Research Laboratories |
12723943 |
29 |
Benzodiazepines as potent and selective bradykinin B1 antagonists.![EBI](/images/logo_chembl.png) |
Merck Research Laboratories |
20369879 |
21 |
Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.![EBI](/images/logo_chembl.png) |
Johnson & Johnson Pharmaceutical Research and Development |
| 4 |
Synthesis and biological activity of new bradykinin pseudopeptide B1 receptor agonists containing alkylic spacers![EBI](/images/logo_chembl.png) |
TBA |
18752949 |
60 |
1-Benzylbenzimidazoles: the discovery of a novel series of bradykinin B(1) receptor antagonists.![EBI](/images/logo_chembl.png) |
Neurogen |
17408249 |
76 |
Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.![EBI](/images/logo_chembl.png) |
Amgen |
17243660 |
42 |
Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.![EBI](/images/logo_chembl.png) |
Amgen |
17228869 |
44 |
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.![EBI](/images/logo_chembl.png) |
Merck Research Laboratories |
15588075 |
33 |
2,3-diaminopyridine bradykinin B1 receptor antagonists.![EBI](/images/logo_chembl.png) |
Merck Research Laboratories |
15546726 |
22 |
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.![EBI](/images/logo_chembl.png) |
Merck Research Laboratories |